EUVIMEDEUVIMED entdecken
Crossref

Transcriptome profiling and metabolic pathway analysis towards reliable biomarker discovery in early-stage lung cancer

Muthu Kumar Thirunavukkarasu, Priyanka Ramesh, Ramanathan Karuppasamy, Shanthi Veerappapillai

Journal of Applied Genetics · 2025

DOI: 10.1007/s13353-024-00847-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Genetics, 2025. Verfasst von Muthu Kumar Thirunavukkarasu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Sciences and Humanities, SR University, Warangal, Telangana, 506371, India. Hauptthemen laut MEDLINE: Lung Neoplasms, Biomarkers, Tumor, Gene Expression Profiling, Metabolic Networks and Pathways. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Earlier diagnosis of lung cancer is crucial for reducing mortality and morbidity in high-risk patients. Liquid biopsy is a critical technique for detecting the cancer earlier and tracking the treatment outcomes. However, noninvasive biomarkers are desperately needed due to the lack of therapeutic sensitivity and early-stage diagnosis. Therefore, we have utilized transcriptomic profiling of early-stage lung cancer patients to discover promising biomarkers and their associated metabolic functions. Initially, PCA highlights the diversity level of gene expression in three stages of lung cancer samples. We have identified two major clusters consisting of highly variant genes among the three stages. Further, a total of 7742, 6611, and 643 genes were identified as DGE for stages I-III respectively. Topological analysis of the protein-protein interaction network resulted in seven candidate biomarkers such as JUN, LYN, PTK2, UBC, HSP90AA1, TP53, and UBB cumulatively for the three stages of lung cancers. Gene enrichment and KEGG pathway analyses aid in the comprehension of pathway mechanisms and regulation of identified hub genes in lung cancer. Importantly, the medial survival rates up to ~ 70 months were identified for hub genes during the Kaplan-Meier survival analysis. Moreover, the hub genes displayed the significance of risk factors during gene expression analysis using TIMER2.0 analysis. Therefore, we have reason that these biomarkers may serve as a prospective targeting candidate with higher treatment efficacy in early-stage lung cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsBiomarkers, TumorGene Expression ProfilingMetabolic Networks and PathwaysTranscriptomeHumansProtein Interaction MapsGene Expression Regulation, NeoplasticNeoplasm StagingEarly Detection of CancerGene Regulatory NetworksMaleKaplan-Meier Estimate

Stichwörter der Autor:innen

CytoHubbaDifferential gene expressionKaplan–Meier analysisRNA-sequencingSubio64

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • School of Sciences and Humanities, SR University, Warangal, Telangana, 506371, India.
  • Bioinformatics Core, College of Agriculture, Agriculture Research and Graduate Education, Purdue University, West Lafayette, IN, 47907, USA.
  • Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India.
  • Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India. shanthi.v@vit.ac.in.

Zitieren

APA

Thirunavukkarasu, M. K., Ramesh, P., Karuppasamy, R., & Veerappapillai, S. (2025). Transcriptome profiling and metabolic pathway analysis towards reliable biomarker discovery in early-stage lung cancer. Journal of Applied Genetics. https://doi.org/10.1007/s13353-024-00847-2

Vancouver

Thirunavukkarasu MK, Ramesh P, Karuppasamy R, Veerappapillai S. Transcriptome profiling and metabolic pathway analysis towards reliable biomarker discovery in early-stage lung cancer. Journal of Applied Genetics. 2025. doi:10.1007/s13353-024-00847-2

BibTeX
@article{Thirunavukkarasu2025,
  author = {Thirunavukkarasu, Muthu Kumar and Ramesh, Priyanka and Karuppasamy, Ramanathan and Veerappapillai, Shanthi},
  title = {Transcriptome profiling and metabolic pathway analysis towards reliable biomarker discovery in early-stage lung cancer},
  journal = {Journal of Applied Genetics},
  year = {2025},
  doi = {10.1007/s13353-024-00847-2}
}
Kostenlos starten →